COVID-19 vaccines highly effective in clinical risk groups
Those used in the UK as effective at preventing symptomatic disease in the majority of people with underlying health conditions as the rest of the population.
Those used in the UK as effective at preventing symptomatic disease in the majority of people with underlying health conditions as the rest of the population.
Data on the real-world efficacy of the COVID-19 vaccines.
National influenza and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasonal respiratory illnesses.
Risk assessments for SARS-CoV-2 variants.
Genomically confirmed case numbers for SARS-CoV-2 variants of concern and variants under investigation.
The symptoms, means of transmission, best means of prevention and treatment of RSV.
Data reports on novel SARS-CoV-2 variants.
Technical briefing documents on novel SARS-CoV-2 variants.
Latest updates on SARS-CoV-2 variants detected in UK.
National influenza and COVID-19 report, monitoring coronavirus (COVID-19) activity, seasonal flu and other seasonal respiratory illnesses.